Elisabeth R Krow-Lucal1, Marcia Regina de Andrade2, Juliana Nunes Abath Cananéa3, Cynthia A Moore4, Priscila Leal Leite5, Brad J Biggerstaff6, Cibelle Mendes Cabral2, Megumi Itoh7, Jadher Percio8, Marcelo Y Wada8, Ann M Powers6, Aristides Barbosa9, Roberta Batista Abath3, J Erin Staples6, Giovanini Evelim Coelho5. 1. Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA; EIS Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2. Epidemiologia Aplicada aos Serviços do Sistema Único de Saúde (Episus), Brasilia, Brazil. 3. Secretariat of Health, Paraíba, Brazil. 4. Division of Congenital and Developmental Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. National Dengue Control Program, Brazil Ministry of Health, Brasilia, Brazil. 6. Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA. 7. EIS Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA. 8. Epidemiologia Aplicada aos Serviços do Sistema Único de Saúde (Episus), Brasilia, Brazil; National Dengue Control Program, Brazil Ministry of Health, Brasilia, Brazil. 9. Brazil Country Office, Centers for Disease Control and Prevention, Brasilia, Brazil.
Abstract
BACKGROUND: In 2015, the number of infants born with microcephaly increased in Paraíba, Brazil, after a suspected Zika virus outbreak. We did a retrospective case-control investigation to assess the association of microcephaly and Zika virus. METHODS: We enrolled cases reported to the national database for microcephaly and born between Aug 1, 2015, and Feb 1, 2016, on the basis of their birth head circumference and total body length. We identified controls from the national birth registry and matched them to cases by location, aiming to enrol a minimum of two controls per case. Mothers of both cases and controls were asked about demographics, exposures, and illnesses and infants were measured at a follow-up visit 1-7 months after birth. We took blood samples from mothers and infants and classified those containing Zika virus IgM and neutralising antibodies as evidence of recent infection. We calculated prevalence of microcephaly and odds ratios (ORs) using a conditional logistic regression model with maximum penalised conditional likelihood, and combined these ORs with exposure probability estimates to determine the attributable risk. FINDINGS: We enrolled 164 of 706 infants with complete information reported with microcephaly at birth, of whom we classified 91 (55%) as having microcephaly on the basis of their birth measurements, 36 (22%) as small, 21 (13%) as disproportionate, and 16 (10%) as not having microcephaly. 43 (26%) of the 164 infants had microcephaly at follow-up for an estimated prevalence of 5·9 per 1000 livebirths. We enrolled 114 control infants matched to the 43 infants classified as having microcephaly at follow-up. Infants with microcephaly at follow-up were more likely than control infants to be younger (OR 0·5, 95% CI 0·4-0·7), have recent Zika virus infection (21·9, 7·0-109·3), or a mother with Zika-like symptoms in the first trimester (6·2, 2·8-15·4). Once Zika virus infection and infant age were controlled for, we found no significant association between microcephaly and maternal demographics, medications, toxins, or other infections. Based on the presence of Zika virus antibodies in infants, we concluded that 35-87% of microcephaly occurring during the time of our investigation in northeast Brazil was attributable to Zika virus. We estimate 2-5 infants per 1000 livebirths in Paraíba had microcephaly attributable to Zika virus. INTERPRETATION: Time of exposure to Zika virus and evidence of infection in the infants were the only risk factors associated with microcephaly. This investigation has improved understanding of the outbreak of microcephaly in northeast Brazil and highlights the need to obtain multiple measurements after birth to establish if an infant has microcephaly and the need for further research to optimise testing criteria for congenital Zika virus infection. FUNDING: Centers for Disease Control and Prevention.
BACKGROUND: In 2015, the number of infants born with microcephaly increased in Paraíba, Brazil, after a suspected Zika virus outbreak. We did a retrospective case-control investigation to assess the association of microcephaly and Zika virus. METHODS: We enrolled cases reported to the national database for microcephaly and born between Aug 1, 2015, and Feb 1, 2016, on the basis of their birth head circumference and total body length. We identified controls from the national birth registry and matched them to cases by location, aiming to enrol a minimum of two controls per case. Mothers of both cases and controls were asked about demographics, exposures, and illnesses and infants were measured at a follow-up visit 1-7 months after birth. We took blood samples from mothers and infants and classified those containing Zika virus IgM and neutralising antibodies as evidence of recent infection. We calculated prevalence of microcephaly and odds ratios (ORs) using a conditional logistic regression model with maximum penalised conditional likelihood, and combined these ORs with exposure probability estimates to determine the attributable risk. FINDINGS: We enrolled 164 of 706 infants with complete information reported with microcephaly at birth, of whom we classified 91 (55%) as having microcephaly on the basis of their birth measurements, 36 (22%) as small, 21 (13%) as disproportionate, and 16 (10%) as not having microcephaly. 43 (26%) of the 164 infants had microcephaly at follow-up for an estimated prevalence of 5·9 per 1000 livebirths. We enrolled 114 control infants matched to the 43 infants classified as having microcephaly at follow-up. Infants with microcephaly at follow-up were more likely than control infants to be younger (OR 0·5, 95% CI 0·4-0·7), have recent Zika virus infection (21·9, 7·0-109·3), or a mother with Zika-like symptoms in the first trimester (6·2, 2·8-15·4). Once Zika virus infection and infant age were controlled for, we found no significant association between microcephaly and maternal demographics, medications, toxins, or other infections. Based on the presence of Zika virus antibodies in infants, we concluded that 35-87% of microcephaly occurring during the time of our investigation in northeast Brazil was attributable to Zika virus. We estimate 2-5 infants per 1000 livebirths in Paraíba had microcephaly attributable to Zika virus. INTERPRETATION: Time of exposure to Zika virus and evidence of infection in the infants were the only risk factors associated with microcephaly. This investigation has improved understanding of the outbreak of microcephaly in northeast Brazil and highlights the need to obtain multiple measurements after birth to establish if an infant has microcephaly and the need for further research to optimise testing criteria for congenital Zika virus infection. FUNDING: Centers for Disease Control and Prevention.
Authors: Ai-Ris Y Collier; Erica N Borducchi; Abishek Chandrashekar; Edward Moseley; Lauren Peter; Nicholas S Teodoro; Joseph Nkolola; Peter Abbink; Dan H Barouch Journal: Am J Reprod Immunol Date: 2020-07-01 Impact factor: 3.886
Authors: Jacob E Attell; Charles Rose; Jeanne Bertolli; Kim Kotzky; Jane Squires; Nevin K Krishna; Ashley Satterfield-Nash; Georgina Peacock; Isabela Ornelas Pereira; Ana Carolina Faria E Silva Santelli; Camille Smith Journal: Infants Young Child Date: 2020-06
Authors: Roziah Ali; Ruziyatul Aznieda Azmi; Nazni Wasi Ahmad; Azahari Abd Hadi; Khairul Asuad Muhamed; Rosilawati Rasli; Cheong Yoon Ling; Henry Anak Chua; Kiew Lian Wan; Han Lim Lee Journal: Am J Trop Med Hyg Date: 2020-05 Impact factor: 2.345
Authors: Romeo R Galang; Greace Alejandra Avila; Diana Valencia; Marcela Daza; Van T Tong; Antonio José Bermúdez; Suzanne M Gilboa; Angélica Rico; Jordan Cates; Oscar Pacheco; Christina M Winfield; Franklyn Prieto; Margaret A Honein; Liliana J Cortés; Cynthia A Moore; Martha L Ospina Journal: J Pediatr Date: 2020-05-13 Impact factor: 4.406
Authors: Marcos A Espinal; Jon K Andrus; Barbara Jauregui; Stephen Hull Waterman; David Michael Morens; Jose Ignacio Santos; Olaf Horstick; Lorraine Ayana Francis; Daniel Olson Journal: Am J Public Health Date: 2019-01-24 Impact factor: 9.308
Authors: Isabela Ornelas Pereira; Ana C F S Santelli; Priscila L Leite; Jacob Attell; Jeanne Bertolli; Kim Kotzky; Wildo N Araújo; Georgina Peacock Journal: Matern Child Health J Date: 2020-11-27